Morgan Stanley keeps Omnicom, Molina and Hexcel at Equal-Weight
Morgan Stanley kept equal-weight ratings on Omnicom, Molina Health and Hexcel, lifting Omnicom's target to $85 and cutting Hexcel's to $92, per Dow Jones.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Morgan Stanley maintained its equal-weight rating on Omnicom, Molina Health and Hexcel, according to a report from Dow Jones Newswires that cites Benzinga ratings data.
The bank raised its Omnicom price target to $85 from $83. For Hexcel, it lowered the target to $92 from $97. No rating change was reported for Molina Health in this update.
why it matters
Price target adjustments like these are routine and usually affect individual stocks rather than the broader market. For the aerospace materials and managed-care names, the update signals a neutral stance from the bank rather than a change in its overall view.
tags
instruments
sources
- Omnicom Is Maintained at Equal-Weight by Morgan Stanley — Dow Jones Newswires, 23 October 2026 at 17:36 UTC
- Molina Health Is Maintained at Equal-Weight by Morgan Stanley — Dow Jones Newswires, 23 October 2026 at 17:35 UTC
- Hexcel Is Maintained at Equal-Weight by Morgan Stanley — Dow Jones Newswires, 23 October 2026 at 17:33 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗